Position in ANIK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$489,607
+$204,276 QoQ
Shares Held
33,466
+70.1% QoQ
Ownership
0.250%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 134 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IEQ CAPITAL, LLC holds $137,938,276 across 20 Drug Manufacturers - Specialty & Generic names. ANIK ranks #14 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
640,304 | $107,916,836 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
26,102 | $14,142,846 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
561,588 | $2,364,285 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
227,421 | $2,274,210 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
29,746 | $1,902,256 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
99,417 | $1,593,654 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
106,098 | $1,537,360 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
41,170 | $1,394,839 |
All Filings in ANIK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $489,607 | 33,466 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $285,331 | 19,678 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $96,763 | 10,069 | Shares | Other | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||